ArticleFrontiers in endocrinology2026
Clinical efficacy, safety, and predictors of treatment response to SGLT2 versus DPP-4 inhibitors in type 2 diabetes: a retrospective comparative study.
Xinfeng Yao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.